Literature DB >> 3129009

Steady-state pharmacokinetics of lithium carbonate in healthy subjects.

R Hunter1.   

Abstract

1. The pharmacokinetics of lithium in six healthy volunteers stabilised on lithium were investigated and appropriate pharmacokinetic parameters calculated. 2. The results illustrate important differences in single and multiple dose lithium pharmacokinetics; the implications for minimising lithium-induced renal damage are discussed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3129009      PMCID： PMC1386362          DOI： 10.1111/j.1365-2125.1988.tb03316.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


  17 in total

1.  THE RELATIONSHIP BETWEEN ENDOGENOUS CREATININE CLEARANCE AND SERUM CREATININE IN RENAL FAILURE.

Authors:  E ENGER; E M BLEGEN
Journal:  Scand J Clin Lab Invest       Date:  1964       Impact factor: 1.713

2.  Prediction of creatinine clearance from serum creatinine.

Authors:  D W Cockcroft; M H Gault
Journal:  Nephron       Date:  1976       Impact factor: 2.847

3.  Serum concentrations of lithium after three proprietary preparations of lithium carbonate (Priadel, Phasal and Camcolit).

Authors:  E H Bennie; A K Manzoor; A M Scott; G S Fell
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

4.  Absorption of lithium following administration of slow-release and conventional preparations.

Authors:  S Tyrer; R P Hullin; N J Birch; J C Goodwin
Journal:  Psychol Med       Date:  1976-02       Impact factor: 7.723

Review 5.  Serum level monitoring and clinical pharmacokinetics of lithium.

Authors:  A Amdisen
Journal:  Clin Pharmacokinet       Date:  1977 Mar-Apr       Impact factor: 6.447

6.  Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent-depressive disorders.

Authors:  P C Baastrup; J C Poulsen; M Schou; K Thomsen; A Amdisen
Journal:  Lancet       Date:  1970-08-15       Impact factor: 79.321

7.  Comparison of serum levels of two sustained-release preparations of lithium carbonate.

Authors:  D M Shaw; R Hewland; A L Johnson; P Hilary-Jones; M R Howlett
Journal:  Curr Med Res Opin       Date:  1974       Impact factor: 2.580

8.  Pharmacokinetics of standard (lithicarb) and sustained-release (Priadel) lithium carbonate preparations in patients.

Authors:  G F Johnson; G E Hunt; J Lewis; B St George
Journal:  Aust N Z J Psychiatry       Date:  1982-03       Impact factor: 5.744

9.  Lithium effects: relation to lithium dose and to plasma peak levels.

Authors:  E T Mellerup; H Dam; G Wildschödtz; O J Rafaelsen
Journal:  Acta Psychiatr Scand       Date:  1979-08       Impact factor: 6.392

10.  Lithium kinetics in single daily dosing.

Authors:  P J Perry; F J Dunner; R L Hahn; M T Tsuang; M J Berg
Journal:  Acta Psychiatr Scand       Date:  1981-10       Impact factor: 6.392
View more
  7 in total

1.  First-dose pharmacokinetics of lithium carbonate in children and adolescents.

Authors:  Robert L Findling; Cornelia B Landersdorfer; Vivian Kafantaris; Mani Pavuluri; Nora K McNamara; Jon McClellan; Jean A Frazier; Linmarie Sikich; Robert Kowatch; Jacqui Lingler; Jon Faber; Perdita Taylor-Zapata; William J Jusko
Journal:  J Clin Psychopharmacol       Date:  2010-08       Impact factor: 3.153

2.  Lithium in Paediatric Patients with Bipolar Disorder: Implications for Selection of Dosage Regimens via Population Pharmacokinetics/Pharmacodynamics.

Authors:  Cornelia B Landersdorfer; Robert L Findling; Jean A Frazier; Vivian Kafantaris; Carl M J Kirkpatrick
Journal:  Clin Pharmacokinet       Date:  2017-01       Impact factor: 6.447

3.  Tenidap sodium decreases renal clearance and increases steady-state concentrations of lithium in healthy volunteers.

Authors:  G Apseloff; K D Wilner; D A von Deutsch; N Gerber
Journal:  Br J Clin Pharmacol       Date:  1995       Impact factor: 4.335

Review 4.  Optimal frequency of lithium administration in the treatment of bipolar disorder: clinical and dosing considerations.

Authors:  Gin S Malhi; Michelle Tanious
Journal:  CNS Drugs       Date:  2011-04       Impact factor: 5.749

Review 5.  Population Pharmacokinetic Analyses of Lithium: A Systematic Review.

Authors:  Janthima Methaneethorn
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-02       Impact factor: 2.441

Review 6.  Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring.

Authors:  Etienne Marc Grandjean; Jean-Michel Aubry
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

Review 7.  Drug Interactions with Lithium: An Update.

Authors:  Patrick R Finley
Journal:  Clin Pharmacokinet       Date:  2016-08       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.